Ninety-day repeated dose toxicity of Ashwagandha (Withania somnifera) root extract in Wistar rats

Ninety-day repeated dose toxicity of Ashwagandha (Withania somnifera) root extract in Wistar rats

Many pharmacological studies have been carried out to describe multiple biological properties of Ashwagandha (Withania somnifera) and the additional safety information on repeated dose toxicity is limited. Therefore, the aim of this study was to obtain safety data for KSM-66 Ashwagandha Root Extract...

Full description

Bibliographic Details
Main Authors:	P. Kalaivani, R. Siva, V. Gayathri, Deepak Langade
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Toxicology Reports
Subjects:	Ashwagandha root extract Toxicity Repeat dose
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214750023000963

Similar Items

Mutagenicity and safety evaluation of Ashwagandha (Withania somnifera) root aqueous extract in different models
by: P. Kalaivani, et al.
Published: (2024-06-01)

Ashwagandha (Withania somnifera) - influence on sleep: review
by: Przemysław Jędruszczak, et al.
Published: (2023-01-01)

DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha)
by: Shazia Siddiqui, et al.
Published: (2021-01-01)

Sub-acute toxicity of Ashwagandha (Withania somnifera) root extract in wistar rats
by: Deepak Langade, et al.
Published: (2023-12-01)

Ashwagandha (Withania somnifera L.) - the plant with proven health-promoting properties
by: Milena Połumackanycz, et al.
Published: (2020-09-01)

Effect of ashwagandha (Withania Somnifera) consumption on the selected physical fitness variables of male sprinters
by: Satpal Yadav
Published: (2015-01-01)

Ashwagandha (Withania somnifera) - Its Antibacterial and Anticancer Activity
by: Aleksandra Mazurkiewicz, et al.
Published: (2024-04-01)

Effect of Ashwagandha (Withania Somnifera) Root Extract Against Gentamicin Induced Changes of Serum Urea and Creatinine Levels in Rats
by: Nayma Sultana, et al.
Published: (2011-12-01)

Histological Evidence of Nephroprotective Effect of Ashwagandha (Withania somnifera) Root Extract against Gentamicin Induced Nephrotoxicity in Rats
by: Sadia Choudhury Shimmi, et al.
Published: (2014-01-01)

Major biochemical constituents of Withania somnifera (ashwagandha) extract: A review of chemical analysis
by: Abdelwahed Mahmoud Tareq, et al.
Published: (2023-03-01)

Antifungal and antibacterial activities of crude withanolides extract from the roots of Withania somnifera (L.) Dunal (Ashwagandha)
by: H. Punetha, et al.
Published: (2010-06-01)

Analyzing the Efficacy of Organic and Inorganic Sources of Nitrogen and Phosphorus on Growth of Ashwagandha (Withania somnifera Dunal.)
by: S Manohar, et al.
Published: (2012-12-01)

Ashwagandha (Withania somnifera) – a herb with versatile medicinal properties empowering human physical and mental health
by: Sonu Gupta, et al.
Published: (2021-09-01)

Protective effect of ashwagandha (Withania somnifera) against neurotoxicity induced by aluminum chloride in rats
by: Mohamed E Elhadidy, et al.
Published: (2018-01-01)

Ashwagandha (Withania somnifera) supercritical CO2 extract derived withanolides mitigates Bisphenol A induced mitochondrial toxicity in HepG2 cells
by: Satyakumar Vidyashankar, et al.
Published: (2014-01-01)

Effects of Ashwagandha (Withania somnifera) Root Extract On Some Serum Liver Marker Enzymes (AST, ALT) In Gentamicin Intoxicated Rats
by: Nayma Sultana, et al.
Published: (2012-06-01)

Stability analysis for yield attributing traits and total alkaloid content in ashwagandha (Withania somnifera L.)
by: Iqbal Ahmed* and R. B. Dubey
Published: (2024-03-01)

Pharmacokinetics and bioequivalence of Withania somnifera (Ashwagandha) extracts – A double blind, crossover study in healthy adults
by: Se-Kwon Kim, et al.
Published: (2023-12-01)

Combining ability studies under the different environmental conditions for root yield traits and total alkaloid content in Ashwagandha (Withania somnifera L.)
by: Iqbal Ahmed*1, R. B. Dubey1 and K. D. Ameta2
Published: (2023-06-01)

Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers
by: Vidyadhar G. Vaidya, et al.
Published: (2024-01-01)

Ashwagandha <i>(Withania somnifera)</i>—Current Research on the Health-Promoting Activities: A Narrative Review
by: Paulina Mikulska, et al.
Published: (2023-03-01)

Efficacy of Withania somnifera supplementation on adult’s cognition and mood
by: A. Remenapp, et al.
Published: (2022-04-01)

Introduction In Vitro Culture Withania Somnifera for Obtain Secondary Metabolites and Further Study
by: R.E. PAVLIKOV
Published: (2014-07-01)

Introduction In Vitro Culture Withania Somnifera for Obtain Secondary Metabolites and Further Study
by: R.E. PAVLIKOV
Published: (2014-06-01)

Introduction In Vitro Culture Withania Somnifera for Obtain Secondary Metabolites and Further Study
by: R.E. PAVLIKOV
Published: (2016-07-01)

Effect of standardized root extract of ashwagandha (Withania somnifera) on well‐being and sexual performance in adult males: A randomized controlled trial
by: Sanjaya Chauhan, et al.
Published: (2022-07-01)

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
by: Nawab John Dar, et al.
Published: (2023-05-01)

Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
by: Harbans Singh, et al.
Published: (2023-09-01)

In vitro antibacterial effect of Withania somnifera root extract on Escherichia coli
by: Mamta Kumari, et al.
Published: (2015-01-01)

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
by: Akash Saggam, et al.
Published: (2021-05-01)

Withania somnifera acts as a potential insect growth regulator in the polyphagous pest, Pericallia ricini
by: Sandeep Kumar Gaur, et al.
Published: (2017-12-01)

Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis
by: Arvind Chopra, et al.
Published: (2021-11-01)

Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
by: Muskan Gupta, et al.
Published: (2019-08-01)

Effects of <i>Withania somnifera</i> on Cortisol Levels in Stressed Human Subjects: A Systematic Review
by: Matteo Della Porta, et al.
Published: (2023-12-01)

Withania somnifera: Advances and Implementation of Molecular and Tissue Culture Techniques to Enhance Its Application
by: Vibha Pandey, et al.
Published: (2017-08-01)

Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy
by: Manali Singh, et al.
Published: (2022-08-01)

Comparative Plastomics of Ashwagandha (<i>Withania</i>, Solanaceae) and Identification of Mutational Hotspots for Barcoding Medicinal Plants
by: Furrukh Mehmood, et al.
Published: (2020-06-01)

Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice
by: Giulia Costa, et al.
Published: (2023-05-01)

Influence of Drying on the quality of Ashwagandha (Withania somnifera)
by: A Agrawal
Published: (2014-05-01)

Benefits of Withania somnifera (Ashwagandha) supplementation in obesity
by: Alicja Nowak, et al.
Published: (2023-05-01)